Medtronic shareholders OK $48 billion Covidien acquisition

SHARE Medtronic shareholders OK $48 billion Covidien acquisition

MINNEAPOLIS — Medtronic shareholders have approved the acquisition the surgical supplier Covidien in a corporate deal valued at about $48 billion.

Some shareholders were angered by the acquisition of Covidien because it moves the legal headquarters of the combined company to Ireland. Covidien is based in Dublin.

The owners of about 75 percent of Medtronic’s outstanding shares voted Tuesday in favor of the deal, which is the largest transaction in the history of the Minneapolis company.

The Star Tribune reports about 100 people attended the investors meeting at the Hyatt Regency in Minneapolis where Medtronic chief executive Omar Ishrak fielded emotionally charged questions.

The deal was also approved by Covidien shareholders Tuesday. It still needs approval from the Irish High Court.

Medtronic is paying $35.19 per share and exchanging each Covidien share for 0.956 shares in the new company.

The Latest
The charges come more than a year after a federal grand jury subpoenaed the agency in May 2021 seeking records on Mustafaa Saleh and two dozen properties the land bank obtained and sold.
Mike Ruemmler, who managed former Mayor Rahm Emanuel’s 2015 re-election campaign, said Tuesday he plans to file paperwork to form an independent expenditure committee bankrolled by business leaders for the purpose of electing moderate alderpersons.
Nick Fuentes was condemned Tuesday by the top two Republican leaders in Congress, Mitch McConnell and Kevin McCarthy — though McCarthy continued to defend President Donald Trump for meeting with him.
Why not come out during fall camp in September and capture the news cycle by celebrating the decision to keep Donovan beyond next season when his original four-year deal was set to expire?